Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial

This publication has 24 references indexed in Scilit:

• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
  Journal of the American College of Cardiology, 2004
• Outcome of primary angioplasty for acute myocardial infarction during routine duty hours versus during off-hours
  Journal of the American College of Cardiology, 2003
• Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction
  Journal of the American College of Cardiology, 2003
• Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes
  Circulation, 2003
• Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction
  Circulation, 2001
• Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction
  New England Journal of Medicine, 2001
• Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) trial
  Journal of the American College of Cardiology, 2000
• Trial of Abciximab With and Without Low-Dose Reteplase for Acute Myocardial Infarction
  Circulation, 2000
• Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction
  JAMA, 2000
• Abciximab Facilitates the Rate and Extent of Thrombolysis
  Circulation, 1999